Efficacy and safety of dapagliflozin add‐on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled study
Dapagliflozin add-on to evogliptin plus metformin improved glycaemic control and was well tolerated by the target patients.
Authors
- Soon Jib Yoo
- In‐Kyung Jeong (ORCID: https://orcid.org/0000-0001-7857-546X)
- Seung Jin Han (ORCID: https://orcid.org/0000-0003-4783-6799)
- Kyung Mook Choi (ORCID: https://orcid.org/0000-0001-6175-0225)
- Won‐Young Lee (ORCID: https://orcid.org/0000-0002-1082-7592)
- In Joo Kim (ORCID: https://orcid.org/0000-0003-1765-0774)
- Kyung Ah Han (ORCID: https://orcid.org/0000-0001-6436-1938)
- Kyoung‐Ah Kim
Institutions
- Korea University Medical Center (KR)
- Kangbuk Samsung Hospital (KR)
- Dongguk University Ilsan Hospital (KR)
- Pusan National University Hospital (KR)
- The Catholic University of Korea Bucheon St. Mary's Hospital (KR)
- Kyung Hee University Hospital at Gangdong (KR)
- Eulji Medical Center (KR)
- Ajou University (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1111/dom.15838
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.36
Funders
- Hanyang University
- Kosin University
- Yonsei University
- Hallym University
- Inha University
- Catholic University of Korea
- Inha University Hospital
- Samsung
- Yonsei University College of Medicine
- Incheon St. Mary's Hospital, Catholic University of Korea